March 16, 2012
In a report released on March 15, industrial and marketing research information provider Fuji-Keizai predicted that Japan’s generic drug market, worth ¥440.1 billion in 2010, will expand by 33.3% to ¥586.5 billion in 2014. In addition to the launch of...read more